Soleus Capital Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.8M | Sell |
|
|||||
|
2025
Q1 | $32.1M | Buy |
|
|||||
|
2024
Q4 | $27.2M | Hold |
|
|||||
|
2024
Q3 | $17M | Hold |
|
|||||
|
2024
Q2 | $18.4M | Hold |
|
|||||
|
2024
Q1 | $32.1M | Hold |
|
|||||
|
2023
Q4 | $25.1M | Sell |
|
|||||
|
2023
Q3 | $24M | Sell |
|
|||||
|
2023
Q2 | $11.1M | Buy |
|
|||||
|
2023
Q1 | $11.3M | Buy |
|
|||||
|
2022
Q4 | $3.53M | Buy |
|
|||||
|
2022
Q3 | $8.75M | Hold |
|
|||||
|
2022
Q2 | $11.6M | Buy |
|
|||||
|
2022
Q1 | $19.1M | Buy |
|
|||||
|
2021
Q4 | $23.3M | Buy |
|
|||||
|
2021
Q3 | $26.5M | Buy |
|
|||||
|
2021
Q2 | $32.9M | Buy |
|